Selegiline for Dogs: Anipryl for Cognitive Dysfunction

What Selegiline Is and Why It Matters for Senior Dogs

Selegiline, sold for dogs under the brand name Anipryl, is a monoamine oxidase B (MAO-B) inhibitor that has been FDA-approved in veterinary medicine for two specific conditions: canine cognitive dysfunction syndrome (CDS) and pituitary-dependent hyperadrenocorticism, the more common form of Cushing’s disease in dogs. It is a member of the same drug class used in human Parkinson’s disease for similar reasons — protection of dopamine activity in the brain.

For owners of senior dogs starting to show signs of cognitive decline — getting lost in familiar rooms, sleeping all day and pacing all night, forgetting house training, losing interest in family interactions — selegiline for dogs is one of the few medications specifically labeled for this use. It does not cure cognitive dysfunction, but it can meaningfully slow the progression and improve day-to-day quality of life when started early in the disease course.

The most important safety point upfront: selegiline interacts dangerously with serotonergic medications including SSRIs like fluoxetine and paroxetine, SNRIs, tramadol, and even St John’s wort. The combination can trigger serotonin syndrome, which is a medical emergency. A washout period is required when switching between selegiline and any of these drugs. We will cover this in detail.

How Selegiline Works in the Brain

Monoamine oxidase B is an enzyme that breaks down dopamine in the brain. By selectively inhibiting MAO-B, selegiline preserves dopamine activity, which is thought to support the cognitive and motor circuits that begin to deteriorate with age. The drug also has antioxidant effects that may protect neurons from oxidative damage, which contributes to age-related decline.

For canine cognitive dysfunction specifically, the goal is to slow further loss and, in many dogs, restore some of what looks like fading personality and engagement. Owners often describe a dog who is “back to themselves” within weeks to months of starting treatment, though responses vary widely. Some dogs respond robustly, others modestly, and some not at all.

Canine Cognitive Dysfunction Syndrome — When to Consider Selegiline

The classic signs that prompt a CDS workup and possible selegiline trial fall under the acronym DISHAA:

• Disorientation — getting stuck in corners, staring at walls, confusion in familiar settings
• Interactions — reduced engagement with family members, less interest in greeting
• Sleep-wake cycle disruption — sleeping all day, pacing or vocalizing all night
• House-soiling — accidents in a previously house-trained dog
• Activity changes — reduced interest in walks, decreased exploration, repetitive behaviors
• Anxiety — new-onset noise sensitivity, separation issues, or generalized restlessness

If your senior dog shows several of these signs, a veterinary visit is warranted. Other conditions can mimic cognitive dysfunction — pain, vision or hearing loss, kidney disease, hypothyroidism, brain tumors — and a workup helps rule them out before starting cognitive-focused treatment. For more on the syndrome itself, see our overview of dog care resources for senior pets.

Selegiline for Pituitary Cushing’s Disease

The second FDA-labeled use for selegiline in dogs is pituitary-dependent hyperadrenocorticism. The mechanism here is different — selegiline is thought to enhance dopaminergic inhibition of the pars intermedia of the pituitary, reducing ACTH output and downstream cortisol. In practice, response rates have been variable, and selegiline is no longer a first-line Cushing’s treatment in most veterinary practices.

The dominant Cushing’s drug today is trilostane, sold under the brand name Vetoryl, which directly inhibits cortisol production at the adrenal gland. Mitotane, another older option, is also still used in selected cases. See our overviews of trilostane for dogs and Addison’s disease in dogs for context on the broader endocrine landscape.

Serotonin Syndrome Risk — The Critical Drug Interaction

This deserves its own section because it can be life-threatening. Selegiline at therapeutic veterinary doses primarily inhibits MAO-B, but at higher doses or in some individuals it can also affect MAO-A, which is involved in serotonin metabolism. Combined with drugs that raise serotonin levels, the result can be serotonin syndrome — a constellation of agitation, tremors, hyperthermia, autonomic instability, and in severe cases seizures and death.

Drugs that should not be combined with selegiline include:

• SSRIs: fluoxetine, paroxetine, sertraline
• SNRIs: venlafaxine, duloxetine
• Tricyclic antidepressants: clomipramine, amitriptyline (often listed as relative contraindications)
• Tramadol — common pain medication
• Mirtazapine — often used as appetite stimulant
• St John’s wort — herbal supplement
• MAO inhibitors used for other purposes (amitraz tick collars contain an MAOI compound)

If your dog is currently on any of these and selegiline is being considered, your veterinarian will plan a washout period of typically two weeks (longer for fluoxetine due to its long half-life — sometimes five weeks) before starting selegiline. The same washout is required when switching from selegiline back to a serotonergic drug.

How to Give Selegiline

Anipryl comes as scored tablets in several sizes, given once daily by mouth. Most veterinarians recommend morning dosing because of the drug’s mild stimulant effect, which can disrupt sleep if given at night. The tablet can be given with or without food.

Owners should expect a slow ramp-up of effect. Improvements in cognitive signs may not be apparent for four to eight weeks, and the maximum benefit may take two to three months to manifest. Set realistic expectations and keep a simple log of behavioral signs — sleep patterns, accidents, engagement, disorientation episodes — so you and your veterinarian can evaluate response objectively rather than from memory. The most common reason owners discontinue selegiline early is impatience: stopping at week three because nothing seems to be happening, when the typical benefit window does not open until weeks four to eight. Calendar a six-week checkpoint as the earliest reasonable date to evaluate response.

Side Effects and What to Watch For

Selegiline is generally well tolerated. Reported side effects include:

• Vomiting or appetite changes (usually transient)
• Restlessness or hyperactivity in some dogs
• Disorientation that paradoxically worsens before improving
• Diarrhea
• Skin reactions (uncommon)

The serious adverse event is serotonin syndrome from a drug interaction, which we covered above. Signs include muscle tremors, agitation, high body temperature, rapid heart rate, dilated pupils, and seizures. This is an emergency — head to the nearest veterinary ER immediately and bring the medication bottle.

Combining Selegiline with Behavioral and Environmental Support

Medication alone is not the whole answer for canine cognitive dysfunction. The best results come from combining selegiline (or other cognitive-support drugs) with:

• Predictable daily routine — same wake, walk, meal, and sleep times
• Mental enrichment — puzzle feeders, scent work, gentle training games
• Cognitive-support diets formulated with antioxidants and medium-chain triglycerides
• Adequate but appropriate exercise for the dog’s mobility
• Nightlights and consistent furniture placement to reduce nighttime confusion
• Companion items like calming pheromones or familiar bedding

Some owners also find that CBD oil for dogs or calming treats for dogs help with the anxiety and sleep-cycle components, though these should be discussed with your vet given the drug interaction concerns with selegiline.

Monitoring and Follow-Up

For dogs on selegiline for cognitive dysfunction, plan a follow-up visit at four to eight weeks to assess response and again at three to six months. Bring your behavioral log. If response has been good, continue indefinitely; if response has been poor and other causes of decline have been ruled out, your vet may discuss adjunctive medications or alternative approaches.

For dogs on selegiline for Cushing’s, monitoring is more intensive and includes ACTH stimulation tests, electrolytes, and clinical signs. Most modern Cushing’s protocols use trilostane instead, but if your dog is doing well on selegiline, do not change without veterinary guidance.

Document everything for these follow-ups. Owners often underestimate how quickly memory of baseline fades — a dog who was disoriented every evening becomes the new normal, and the contrast with the pre-treatment state is hard to recall accurately three months later. A short weekly note (one or two sentences about sleep, accidents, engagement, and any unusual behavior) gives you and your veterinarian a real timeline to work from. The same is true for any side effects — note when they appeared, when they resolved, and whether they coincided with dose changes or other medication adjustments.

Frequently Asked Questions

How long does it take selegiline to work for cognitive dysfunction?

Most dogs show some response within four to eight weeks, with maximum effect at two to three months. Keep a behavioral log so you have objective data rather than relying on day-to-day impressions, which can be deceiving.

Can selegiline reverse cognitive dysfunction?

It can sometimes restore meaningful function and engagement, but it does not cure the underlying neurodegeneration. Think of it as slowing the disease and supporting brain function, not reversing damage. Earlier starts tend to produce better results.

Why can’t I give selegiline with my dog’s tramadol?

The combination raises the risk of serotonin syndrome, which can be life-threatening. If your dog is on chronic tramadol and you want to start selegiline, your veterinarian will need to plan a washout period and possibly switch to a different pain medication. Never combine these without explicit veterinary direction.

What is the washout period for fluoxetine before starting selegiline?

Fluoxetine has an unusually long half-life, and most behavior specialists recommend a five-week washout before starting selegiline. For shorter-acting SSRIs, two weeks is more typical. Your veterinarian will tailor the timing to your dog’s specific medication history.

Does selegiline help with anxiety in older dogs?

Anxiety is common in canine cognitive dysfunction, and as cognitive function improves on selegiline, anxiety often improves too. Selegiline is not, however, a primary anxiety medication, and dogs with anxiety unrelated to cognitive decline may need a different drug — but never an SSRI combined with selegiline.

Is selegiline safe for dogs with kidney or liver disease?

It can usually be used with monitoring, but dose adjustment may be needed and your veterinarian will assess on a case-by-case basis. Bring current bloodwork to the appointment where selegiline is being discussed.

Selegiline for dogs is one of the most useful tools available for canine cognitive dysfunction, but only when its serious drug interactions are respected. Any new behavioral changes in a senior dog warrant a veterinary visit before assuming aging is the explanation. For broader senior dog support, browse our dog care library. The earlier cognitive changes are caught and addressed, the better the response to medical and environmental support tends to be — do not write off subtle changes in your senior dog as just getting old. They may be the first signal of a treatable process.